• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » CareFusion crushes it in final quarter

CareFusion crushes it in final quarter

February 5, 2015 By Brad Perriello

CareFusion crushes it in final quarter

CareFusion (NYSE:CFN) today crushed Wall Street’s expectations with what’s likely its final quarterly report before its merger with Becton Dickinson & Co. (NYSE:BDX).

The San Diego-based medical device company posted profit growth of 78.4% to $173 million, or 83¢ per share, on sales growth of 15.9% to $1.07 billion for the 3 months ended Dec. 31, 2014, compared with the same period in 2013.

Adjusted to exclude 1-time items, earnings per share were 99¢, a full 20¢ above expectations on Wall Street, where analysts were looking for sales of just $1.01 billion.

"Our team remained disciplined in their execution and saw the benefit from investments we’ve made during the past 4 years, with record quarterly results across the company," chairman & CEO Kieran Gallahue said in a statement.

“Results in the medical systems segment were again highlighted by the strength of our medication management offering, anchored by another quarter of strong committed contracts for our industry leading Pyxis dispensing technologies and Alaris infusion systems. In the procedural solutions segment, we continued to grow faster than the market due to the strength of our clinically differentiated products and the impact of our Vital Signs acquisition. Outside the U.S. – where we have been actively refining our offerings and go-to-market models – we recorded double-digit revenue growth in Europe, Asia, Canada and Latin America," Gallahue said.

"I want to thank CareFusion employees around the world for the results they deliver every day for customers and patients. We have built a unique company, and I know I speak for our entire leadership team when I say how proud we have been to work alongside such a dedicated group of individuals," he said.

Last October BD agreed to pay $12.2 billion for CareFusion, in a deal that’s expected to close before the end of the 1st calendar quarter. BD earlier today posted its fiscal 1st-quarter results, reporting profits of $236 million, or $1.20 per share, on sales of $2.05 billion for the 3 months ended Dec. 31, 2014, for a bottom-line slide of 12.9% on sales growth of 1.8%. Excluding some $97 million in pre-tax expenses, however, adjusted earnings per share were $1.53, a full dime ahead of analysts’ expectations (Wall Street was also looking for sales of $2.01 billion). Much of the excluded expenses stemmed from the pending CareFusion acquisition.

Filed Under: MassDevice Earnings Roundup, Mergers & Acquisitions, News Well Tagged With: 2014, becton dickinson, CareFusion Corp., Q4

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy